Safety of Intraoperative Use of Muscle Relaxants and Their Reversal Agent Neostigmine
This study is ongoing, but not recruiting participants.
Massachusetts General Hospital
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Matthias Eikermann, Massachusetts General Hospital
First received: October 29, 2012
Last updated: March 16, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2016|
|Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|